NCT04704154 2025-04-18A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid TumorsBayerPhase 2 Completed175 enrolled 20 charts
NCT03520842 2023-08-01Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung CancerStanford UniversityPhase 2 Completed22 enrolled 20 charts